Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Given Consensus Rating of "Hold" by Brokerages

Key Points

• Acadia Healthcare has a consensus analyst rating of “Hold”, based on coverage from 16 analysts. The mix includes 2 sell ratings, 7 holds, 6 buys, and 1 strong buy, with an average 12-month price target of about $26.04.
• The company recently posted better-than-expected quarterly results, reporting EPS of $0.37 versus $0.28 expected and revenue of $828.8 million versus $823.5 million expected. Revenue rose 7.6% year over year, and the firm guided Q2 2026 EPS to $0.30-$0.40.
• Recent analyst updates were generally positive on price targets, with firms such as RBC and Guggenheim raising targets to $31.00, while others maintained neutral stances. The stock was trading near $25.18, below its 52-week high of $30.20 but well above its low of $11.43.

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) have been given a consensus rating of "Hold" by the sixteen analysts that are presently covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation, six have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $26.0385.

ACHC has been the topic of several research reports. Leerink Partners upped their price objective on Acadia Healthcare from $14.00 to $22.00 and gave the company a "market perform" rating in a research note on Thursday, February 26th. Barclays lifted their target price on Acadia Healthcare from $20.00 to $25.00 and gave the company an "equal weight" rating in a research note on Thursday, April 30th. Royal Bank Of Canada raised their target price on Acadia Healthcare from $28.00 to $31.00 and gave the company an "outperform" rating in a research note on Monday, May 4th. Guggenheim raised their target price on Acadia Healthcare from $26.00 to $31.00 and gave the company a "buy" rating in a research note on Monday, May 4th. Finally, Jefferies Financial Group restated a "hold" rating and issued a $24.50 price target on shares of Acadia Healthcare in a research note on Monday, April 20th.

Acadia Healthcare Price Performance

ACHC stock opened at $25.18 on Monday. The company's 50 day simple moving average is $24.90 and its 200-day simple moving average is $19.13. The firm has a market capitalization of $2.32 billion, a PE ratio of -2.06, a P/E/G ratio of 8.44 and a beta of 0.73. Acadia Healthcare has a 12 month low of $11.43 and a 12 month high of $30.20. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.71.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.09. The business had revenue of $828.80 million for the quarter, compared to analysts' expectations of $823.51 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The company's quarterly revenue was up 7.6% on a year-over-year basis. During the same period last year, the company earned $0.40 earnings per share. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Equities analysts expect that Acadia Healthcare will post 1.49 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Acadia Healthcare

A number of institutional investors have recently modified their holdings of ACHC. EverSource Wealth Advisors LLC boosted its stake in shares of Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company's stock worth $32,000 after acquiring an additional 497 shares in the last quarter. Wells Fargo & Company MN lifted its stake in shares of Acadia Healthcare by 208.9% in the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company's stock valued at $32,000 after buying an additional 1,510 shares during the period. Bayforest Capital Ltd bought a new stake in shares of Acadia Healthcare in the fourth quarter valued at about $52,000. Hantz Financial Services Inc. raised its stake in shares of Acadia Healthcare by 501.9% in the third quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company's stock valued at $54,000 after purchasing an additional 1,822 shares in the last quarter. Finally, GAMMA Investing LLC raised its stake in shares of Acadia Healthcare by 124.7% in the fourth quarter. GAMMA Investing LLC now owns 4,862 shares of the company's stock valued at $69,000 after purchasing an additional 2,698 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.